Stock Analysis on Net
Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

$24.99

Common-Size Balance Sheet: Assets

Paying users area

Try for free

Pfizer Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Pfizer Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents
Short-term investments
Trade accounts receivable, less allowance for doubtful accounts
Inventories
Current tax assets
Other current assets
Current assets of discontinued operations and other assets held for sale
Current assets
Equity-method investments
Long-term investments
Property, plant and equipment
Identifiable intangible assets
Goodwill
Noncurrent deferred tax assets and other noncurrent tax assets
Other noncurrent assets
Noncurrent assets
Total assets

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Pfizer Inc. current assets as a percentage of total assets decreased from 2021 to 2022 and from 2022 to 2023.
Property, plant and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Pfizer Inc. property, plant and equipment as a percentage of total assets increased from 2021 to 2022 and from 2022 to 2023.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Pfizer Inc. noncurrent assets as a percentage of total assets increased from 2021 to 2022 and from 2022 to 2023.